The Role of Extracellular Vesicles in Efferocytosis
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Efferocytosis is the physiological process of phagocytic clearance of apoptotic cells by both professional phagocytic cells, such as macrophages, and non-professional phagocytic cells, such as epithelial cells. This process is crucial for maintaining tissue homeostasis in normal physiology. Any defects in efferocytosis can lead to pathological consequences and result in inflammatory diseases. Extracellular vesicles (EVs), including exosomes, microvesicles (MVs), and apoptotic vesicles (ApoVs), play a crucial role in proper efferocytosis. These EVs can significantly impact efferocytosis by affecting the polarization of macrophages and impacting calreticulin (CRT), TAM receptors, and MFG-E8. With further knowledge of these effects, new treatment strategies can be proposed for many inflammatory diseases caused by efferocytosis disorders. This review article aims to investigate the role of EVs during efferocytosis and its potential clinical applications in inflammatory diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
Mini reviews in medicinal chemistry - (2023) vom: 05. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Panahi, Susan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Apoptotic bodies |
---|
Anmerkungen: |
Date Revised 20.10.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0113895575247690230926113455 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363517235 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363517235 | ||
003 | DE-627 | ||
005 | 20231226093522.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0113895575247690230926113455 |2 doi | |
028 | 5 | 2 | |a pubmed24n1211.xml |
035 | |a (DE-627)NLM363517235 | ||
035 | |a (NLM)37859308 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Panahi, Susan |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Role of Extracellular Vesicles in Efferocytosis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Efferocytosis is the physiological process of phagocytic clearance of apoptotic cells by both professional phagocytic cells, such as macrophages, and non-professional phagocytic cells, such as epithelial cells. This process is crucial for maintaining tissue homeostasis in normal physiology. Any defects in efferocytosis can lead to pathological consequences and result in inflammatory diseases. Extracellular vesicles (EVs), including exosomes, microvesicles (MVs), and apoptotic vesicles (ApoVs), play a crucial role in proper efferocytosis. These EVs can significantly impact efferocytosis by affecting the polarization of macrophages and impacting calreticulin (CRT), TAM receptors, and MFG-E8. With further knowledge of these effects, new treatment strategies can be proposed for many inflammatory diseases caused by efferocytosis disorders. This review article aims to investigate the role of EVs during efferocytosis and its potential clinical applications in inflammatory diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Microvesicles | |
650 | 4 | |a TAM receptors | |
650 | 4 | |a apoptotic bodies | |
650 | 4 | |a clearance of ACs | |
650 | 4 | |a efferocytosis. | |
650 | 4 | |a exosomes | |
700 | 1 | |a Yazdi, Zohreh |e verfasserin |4 aut | |
700 | 1 | |a Sanchouli, Mahboubeh |e verfasserin |4 aut | |
700 | 1 | |a Sajadi, Fatemehsadat |e verfasserin |4 aut | |
700 | 1 | |a Motavasselian, Fateme |e verfasserin |4 aut | |
700 | 1 | |a Maghareh Abed, Hedyeh |e verfasserin |4 aut | |
700 | 1 | |a Beygi, Zahra |e verfasserin |4 aut | |
700 | 1 | |a Gheibihayat, Seyed Mohammad |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mini reviews in medicinal chemistry |d 2001 |g (2023) vom: 05. Okt. |w (DE-627)NLM121595404 |x 1875-5607 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:05 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0113895575247690230926113455 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 05 |c 10 |